Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Paul Bunn

Concepts (1215)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
343
2024
2342
20.210
Why?
Carcinoma, Non-Small-Cell Lung
171
2024
1049
15.650
Why?
ErbB Receptors
69
2024
607
6.550
Why?
Antineoplastic Agents
103
2023
2046
5.990
Why?
Antineoplastic Combined Chemotherapy Protocols
95
2024
1560
5.670
Why?
Carcinoma, Small Cell
105
2008
169
5.020
Why?
Small Cell Lung Carcinoma
14
2024
88
4.580
Why?
Quinazolines
38
2016
243
4.520
Why?
Protein Kinase Inhibitors
32
2023
887
3.210
Why?
Paclitaxel
31
2011
217
2.580
Why?
Carboplatin
24
2019
139
2.280
Why?
Guanine
11
2007
76
2.100
Why?
Deoxycytidine
14
2004
164
2.000
Why?
Glutamates
11
2007
57
1.920
Why?
Molecular Targeted Therapy
13
2019
391
1.880
Why?
Neoplasm Staging
63
2018
1282
1.820
Why?
Adenocarcinoma
31
2017
893
1.750
Why?
Antibodies, Monoclonal
45
2018
1366
1.700
Why?
Biomarkers, Tumor
37
2021
1164
1.620
Why?
Humans
525
2024
129626
1.610
Why?
Neoadjuvant Therapy
9
2023
379
1.440
Why?
Antimetabolites, Antineoplastic
10
2007
91
1.420
Why?
Receptor, ErbB-2
12
2019
326
1.420
Why?
Taxoids
13
2013
98
1.420
Why?
Mutation
30
2024
3717
1.380
Why?
Skin Neoplasms
55
2010
829
1.340
Why?
Clinical Trials as Topic
51
2024
1005
1.340
Why?
Gene Expression Regulation, Neoplastic
24
2018
1336
1.300
Why?
Lymphoma
47
1991
199
1.250
Why?
Combined Modality Therapy
52
2023
1203
1.240
Why?
Antineoplastic Agents, Phytogenic
10
2007
187
1.220
Why?
Etoposide
26
2023
148
1.190
Why?
Survival Analysis
34
2019
1269
1.120
Why?
Cisplatin
31
2018
299
1.110
Why?
Vinblastine
8
2003
70
1.100
Why?
Carcinoma, Squamous Cell
21
2023
627
1.100
Why?
Sezary Syndrome
36
1996
44
1.070
Why?
Protein-Tyrosine Kinases
10
2023
431
1.070
Why?
Lymphoma, T-Cell, Cutaneous
9
2010
43
1.020
Why?
Drug Resistance, Neoplasm
19
2023
752
1.000
Why?
Antibodies, Monoclonal, Humanized
14
2023
757
0.990
Why?
Mycosis Fungoides
38
1996
61
0.990
Why?
Aged
142
2024
22061
0.980
Why?
Erlotinib Hydrochloride
12
2015
70
0.970
Why?
In Situ Hybridization, Fluorescence
22
2018
313
0.970
Why?
Precision Medicine
5
2024
387
0.940
Why?
Bradykinin
9
2005
45
0.940
Why?
Liposomes
3
2024
171
0.930
Why?
Pemetrexed
14
2024
32
0.920
Why?
Tumor Cells, Cultured
31
2014
943
0.880
Why?
Immunotherapy
13
2020
596
0.870
Why?
Middle Aged
169
2024
31136
0.870
Why?
Proto-Oncogene Proteins
15
2023
636
0.860
Why?
Folic Acid Antagonists
4
2005
9
0.850
Why?
Angiogenesis Inhibitors
8
2018
219
0.830
Why?
Prognosis
52
2019
3774
0.810
Why?
Gene Dosage
10
2018
143
0.790
Why?
Male
205
2024
63670
0.770
Why?
Immunohistochemistry
25
2020
1685
0.760
Why?
Neutropenia
12
2022
137
0.760
Why?
Female
198
2024
68734
0.750
Why?
Survival Rate
23
2020
1872
0.730
Why?
Antigens, Neoplasm
14
2009
308
0.720
Why?
Enzyme Inhibitors
10
2016
827
0.710
Why?
Gene Amplification
9
2019
104
0.710
Why?
Receptor Protein-Tyrosine Kinases
10
2022
231
0.700
Why?
Smoking
20
2019
1500
0.690
Why?
Chemotherapy, Adjuvant
10
2015
377
0.670
Why?
Retirement
1
2020
26
0.650
Why?
Medical Oncology
6
2003
269
0.640
Why?
Brain Neoplasms
18
2023
1145
0.630
Why?
Pathologists
1
2019
16
0.620
Why?
Treatment Outcome
42
2023
10219
0.610
Why?
Aged, 80 and over
36
2024
7052
0.590
Why?
Tubulin Modulators
1
2018
9
0.580
Why?
Furans
1
2018
23
0.580
Why?
Sputum
11
2019
302
0.570
Why?
Ketones
1
2018
48
0.570
Why?
Acrylamides
3
2024
57
0.560
Why?
T-Lymphocytes
54
2020
1936
0.550
Why?
Randomized Controlled Trials as Topic
20
2018
1365
0.550
Why?
Karnofsky Performance Status
1
2016
37
0.540
Why?
Global Health
3
2024
328
0.530
Why?
Aurora Kinase B
1
2016
8
0.530
Why?
Thymidylate Synthase
4
2005
12
0.520
Why?
Cell Division
23
2007
796
0.520
Why?
Sulindac
5
2007
15
0.520
Why?
Proto-Oncogene Proteins c-met
6
2020
74
0.510
Why?
Interferon Type I
12
1995
139
0.500
Why?
Pneumonectomy
3
2015
151
0.500
Why?
Awards and Prizes
1
2016
64
0.500
Why?
Neoplasm Proteins
5
2009
419
0.490
Why?
Dose-Response Relationship, Drug
22
2016
2011
0.490
Why?
Organophosphates
1
2016
120
0.490
Why?
Gene Rearrangement
8
2018
148
0.480
Why?
Adult
123
2024
35599
0.480
Why?
Cell Cycle
12
2015
588
0.480
Why?
Precancerous Conditions
7
2018
160
0.460
Why?
Cell Line, Tumor
18
2019
3186
0.460
Why?
Chemoprevention
5
2019
91
0.450
Why?
Genomics
3
2020
718
0.440
Why?
Genes, erbB-2
8
2017
28
0.430
Why?
Esophagitis
3
2012
67
0.420
Why?
Disease Progression
15
2024
2627
0.420
Why?
Neoplasms
10
2010
2455
0.420
Why?
Genes, erbB-1
6
2015
17
0.420
Why?
Cadherins
6
2012
190
0.410
Why?
Cell Transformation, Neoplastic
6
2004
326
0.410
Why?
Aniline Compounds
2
2024
97
0.410
Why?
AMP-Activated Protein Kinases
1
2014
191
0.390
Why?
Neoplasm Metastasis
16
2024
611
0.390
Why?
Mass Screening
6
2020
1190
0.380
Why?
Mice, Nude
18
2017
682
0.380
Why?
Neoplasm Recurrence, Local
10
2024
958
0.380
Why?
Disease-Free Survival
11
2018
646
0.380
Why?
Ribonucleotide Reductases
4
2004
31
0.380
Why?
Drug Screening Assays, Antitumor
10
2009
191
0.370
Why?
Melanoma
5
2022
730
0.370
Why?
Neuropeptides
6
1998
71
0.370
Why?
Drug Administration Schedule
18
2011
767
0.360
Why?
Pyridines
6
2013
478
0.360
Why?
Early Detection of Cancer
7
2024
370
0.360
Why?
TOR Serine-Threonine Kinases
1
2014
398
0.360
Why?
Proto-Oncogene Proteins p21(ras)
9
2019
259
0.360
Why?
Bronchi
7
2018
249
0.360
Why?
National Cancer Institute (U.S.)
1
2010
43
0.350
Why?
Esophagus
1
2012
248
0.340
Why?
Time Factors
33
2018
6555
0.330
Why?
Signal Transduction
18
2017
4931
0.330
Why?
Animals
67
2019
35391
0.330
Why?
Head and Neck Neoplasms
4
2009
544
0.330
Why?
Genotype
2
2014
1833
0.330
Why?
Fever
5
2001
299
0.320
Why?
Cell Proliferation
9
2018
2373
0.320
Why?
Drug Delivery Systems
2
2010
333
0.320
Why?
Predictive Value of Tests
12
2014
1947
0.310
Why?
Phosphorylation
6
2016
1713
0.310
Why?
Biomedical Research
5
2024
640
0.310
Why?
Drug Monitoring
1
2010
215
0.310
Why?
Receptors, Vascular Endothelial Growth Factor
3
2009
107
0.300
Why?
Salvage Therapy
2
2007
136
0.300
Why?
Topotecan
3
2024
12
0.300
Why?
Drug Therapy, Combination
28
2002
1042
0.300
Why?
Calcium
6
2002
1212
0.300
Why?
B7-H1 Antigen
2
2022
198
0.300
Why?
Pyrazoles
5
2013
404
0.290
Why?
Xenograft Model Antitumor Assays
8
2019
808
0.290
Why?
Lymphoma, Non-Hodgkin
6
2001
78
0.290
Why?
Meta-Analysis as Topic
6
2017
170
0.280
Why?
Cancer Vaccines
1
2009
164
0.280
Why?
Flow Cytometry
14
2006
1159
0.280
Why?
Mesothelioma
3
2004
38
0.280
Why?
Neoplasms, Experimental
4
2002
170
0.270
Why?
Biomarkers
4
2023
3968
0.270
Why?
Radiation-Sensitizing Agents
2
1997
39
0.270
Why?
Leukemia
16
2018
229
0.270
Why?
Receptors, KIR
2
2018
96
0.270
Why?
Camptothecin
5
2017
110
0.260
Why?
Oligopeptides
4
2005
258
0.260
Why?
ras Proteins
7
2014
144
0.260
Why?
Protease Inhibitors
2
2004
107
0.260
Why?
Gene Expression Profiling
9
2016
1687
0.250
Why?
Oncogene Proteins, Fusion
3
2018
201
0.250
Why?
Phosphatidylinositol 3-Kinases
4
2023
361
0.250
Why?
Interferons
7
1995
191
0.250
Why?
Bradykinin Receptor Antagonists
2
2002
3
0.250
Why?
Lung
14
2023
3938
0.250
Why?
Mice
32
2019
16961
0.250
Why?
Thrombocytopenia
8
2001
186
0.250
Why?
Proto-Oncogene Proteins B-raf
5
2015
210
0.240
Why?
Carcinoma in Situ
4
2019
45
0.240
Why?
Recombinant Proteins
14
1998
1308
0.240
Why?
Apoptosis
9
2018
2492
0.240
Why?
Topoisomerase I Inhibitors
3
2024
16
0.230
Why?
Cyclooxygenase Inhibitors
2
2002
80
0.230
Why?
Antigens, Surface
10
1988
152
0.230
Why?
Genes, ras
5
2015
95
0.230
Why?
Breast Neoplasms
9
2018
2133
0.230
Why?
Tankyrases
2
2016
14
0.230
Why?
Indium Radioisotopes
5
1991
13
0.230
Why?
Radiotherapy Dosage
13
2007
251
0.220
Why?
Asymptomatic Infections
1
2024
26
0.220
Why?
Neovascularization, Pathologic
7
2015
296
0.220
Why?
Boronic Acids
1
2004
37
0.220
Why?
Committee Membership
1
2003
2
0.220
Why?
Leukemia, Lymphoid
7
1987
27
0.220
Why?
Transplantation, Heterologous
9
2006
192
0.210
Why?
Volatile Organic Compounds
3
2013
57
0.210
Why?
Organophosphorus Compounds
1
2004
78
0.210
Why?
United States
22
2020
13871
0.210
Why?
Organizational Objectives
1
2003
73
0.210
Why?
Liver Neoplasms
7
2015
639
0.210
Why?
Retrospective Studies
19
2024
14522
0.210
Why?
Pyrazines
1
2004
87
0.210
Why?
Anticarcinogenic Agents
1
2004
77
0.210
Why?
Oncogene Addiction
1
2023
5
0.210
Why?
Delivery of Health Care
1
2010
898
0.210
Why?
HTLV-I Infections
2
1996
22
0.210
Why?
Follow-Up Studies
18
2019
4894
0.200
Why?
Tumor Microenvironment
3
2023
627
0.200
Why?
Neoplasm Transplantation
11
2004
256
0.200
Why?
Receptor, ErbB-3
3
2009
44
0.200
Why?
Bronchoscopy
10
2019
216
0.200
Why?
Cluster Analysis
4
2016
482
0.200
Why?
Doxorubicin
22
2002
329
0.200
Why?
Penicillins
22
1969
57
0.200
Why?
Airway Obstruction
2
2003
152
0.200
Why?
Anti-Bacterial Agents
23
2001
1705
0.200
Why?
Iodine Radioisotopes
5
1992
142
0.200
Why?
Organoplatinum Compounds
3
2006
41
0.200
Why?
Drug Synergism
6
2016
370
0.200
Why?
Growth Substances
4
2000
150
0.190
Why?
Biopsy
12
2023
1088
0.190
Why?
Carcinoma, Bronchogenic
10
1984
19
0.190
Why?
Alkyl and Aryl Transferases
1
2002
53
0.190
Why?
Carcinoma, Transitional Cell
1
2022
59
0.190
Why?
Roxithromycin
1
2001
1
0.190
Why?
Iloprost
2
2012
45
0.190
Why?
DNA, Neoplasm
8
2013
157
0.190
Why?
Societies
1
2001
39
0.190
Why?
Research Design
7
2008
1045
0.190
Why?
Biological Products
2
2023
205
0.180
Why?
Neprilysin
2
1998
48
0.180
Why?
Quality of Life
5
2022
2688
0.180
Why?
Biomarkers, Pharmacological
2
2019
26
0.180
Why?
Cell Line
24
2000
2784
0.180
Why?
Diarrhea
1
2022
182
0.180
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2014
136
0.180
Why?
Cell Cycle Checkpoints
2
2018
95
0.180
Why?
Pleural Neoplasms
2
2016
24
0.180
Why?
Antibiotic Prophylaxis
1
2001
101
0.170
Why?
Prospective Studies
15
2023
7135
0.170
Why?
Smoking Prevention
1
2001
163
0.170
Why?
Artificial Intelligence
1
2023
245
0.170
Why?
Societies, Medical
2
2003
744
0.170
Why?
DNA Copy Number Variations
2
2018
168
0.170
Why?
Programmed Cell Death 1 Receptor
2
2022
232
0.170
Why?
Ki-67 Antigen
4
2015
108
0.170
Why?
Age Factors
7
2016
3152
0.170
Why?
Adenocarcinoma, Bronchiolo-Alveolar
4
2012
19
0.170
Why?
Oncogenes
4
2016
110
0.170
Why?
Patient Participation
1
2003
414
0.160
Why?
Carcinoma, Large Cell
4
2012
15
0.160
Why?
GTP Phosphohydrolases
3
2015
86
0.160
Why?
Urinary Bladder Neoplasms
1
2022
226
0.160
Why?
Vaping
1
2020
54
0.160
Why?
Epidermal Growth Factor
4
2013
169
0.160
Why?
Kaplan-Meier Estimate
6
2016
851
0.160
Why?
Lymph Nodes
17
1991
472
0.160
Why?
Histone Deacetylase Inhibitors
3
2012
209
0.160
Why?
Aminoquinolines
1
2019
21
0.160
Why?
Antibodies, Viral
12
2024
602
0.160
Why?
Neuroendocrine Tumors
1
2020
99
0.160
Why?
Electronic Nicotine Delivery Systems
1
2020
89
0.150
Why?
Practice Guidelines as Topic
3
2019
1501
0.150
Why?
Friends
1
2019
52
0.150
Why?
Structure-Activity Relationship
6
2018
545
0.150
Why?
Trastuzumab
4
2002
100
0.150
Why?
Gene Expression
6
2008
1465
0.150
Why?
Genetic Predisposition to Disease
3
2011
2274
0.150
Why?
Radiotherapy, Adjuvant
3
2004
208
0.150
Why?
DNA Methylation
3
2018
611
0.150
Why?
Wasting Syndrome
1
1998
12
0.150
Why?
Homeodomain Proteins
3
2010
494
0.150
Why?
Leukemia-Lymphoma, Adult T-Cell
2
1996
13
0.150
Why?
History, 21st Century
1
2019
186
0.150
Why?
Clinical Trials, Phase II as Topic
3
2004
72
0.150
Why?
Receptor, IGF Type 1
2
2010
64
0.150
Why?
Caspase 3
2
2018
245
0.150
Why?
Interferon-alpha
4
1995
194
0.150
Why?
Immunoenzyme Techniques
5
2014
212
0.140
Why?
Tumor Escape
1
2018
39
0.140
Why?
Proto-Oncogenes
2
2014
29
0.140
Why?
Forecasting
4
2003
361
0.140
Why?
Smoking Cessation
3
2019
408
0.140
Why?
Young Adult
10
2020
12455
0.140
Why?
Lung Injury
1
2020
211
0.140
Why?
Lung Diseases
6
2015
741
0.140
Why?
Cranial Irradiation
2
1995
67
0.140
Why?
CpG Islands
1
2018
152
0.140
Why?
Folic Acid
4
2002
184
0.140
Why?
Genetic Association Studies
2
2017
362
0.140
Why?
Vitamin B 12
3
2002
122
0.140
Why?
Clinical Protocols
1
2019
254
0.140
Why?
Cyclophosphamide
19
2001
234
0.140
Why?
Mutagenesis, Insertional
1
2017
65
0.140
Why?
Bone Marrow
10
1992
273
0.140
Why?
Multiple Myeloma
5
1997
125
0.140
Why?
Cetuximab
4
2008
94
0.140
Why?
Palliative Care
6
2003
702
0.140
Why?
Drug Evaluation
15
1992
82
0.140
Why?
Proportional Hazards Models
6
2016
1198
0.140
Why?
Receptors, KIR2DL3
1
2016
9
0.140
Why?
Receptors, KIR2DL4
1
2016
4
0.140
Why?
HLA Antigens
4
1988
234
0.130
Why?
Receptors, KIR2DL1
1
2016
18
0.130
Why?
Receptors, KIR3DL1
1
2016
17
0.130
Why?
Tumor Suppressor Protein p53
2
2017
507
0.130
Why?
Patients
1
2018
169
0.130
Why?
Interleukin-2
3
1995
437
0.130
Why?
Polyploidy
1
2016
18
0.130
Why?
DNA Mutational Analysis
6
2017
382
0.130
Why?
RNA, Messenger
7
2014
2708
0.130
Why?
Genes, myc
1
2016
49
0.130
Why?
Chemoradiotherapy
1
2018
208
0.130
Why?
Patient Selection
7
2008
661
0.130
Why?
Pleural Effusion, Malignant
1
2016
10
0.130
Why?
Granulocyte Colony-Stimulating Factor
4
2001
73
0.130
Why?
Translocation, Genetic
1
2016
96
0.130
Why?
Bone Neoplasms
4
2015
229
0.130
Why?
Lymphoma, AIDS-Related
1
1996
14
0.130
Why?
Genetic Therapy
4
2015
289
0.130
Why?
Empathy
2
2009
166
0.130
Why?
Clinical Trials, Phase III as Topic
3
2016
93
0.130
Why?
Human T-lymphotropic virus 1
1
1996
28
0.130
Why?
Computational Biology
2
2018
596
0.120
Why?
Dimerization
3
2002
192
0.120
Why?
Molecular Biology
1
2016
56
0.120
Why?
Cohort Studies
9
2019
5426
0.120
Why?
Radiosurgery
2
2014
321
0.120
Why?
Nerve Tissue Proteins
1
1999
569
0.120
Why?
Membrane Proteins
3
2015
1125
0.120
Why?
Peritoneal Neoplasms
1
2016
86
0.120
Why?
Disease Models, Animal
5
2016
4078
0.120
Why?
Tumor Burden
1
2016
286
0.120
Why?
Ifosfamide
4
2008
34
0.120
Why?
Remission Induction
7
2019
274
0.120
Why?
Sex Factors
6
2015
1970
0.120
Why?
Patient-Specific Modeling
1
2014
39
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2016
204
0.120
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
147
0.110
Why?
Up-Regulation
3
2002
840
0.110
Why?
Amino Acid Sequence
6
1999
2057
0.110
Why?
HIV
1
1996
227
0.110
Why?
Prevalence
4
2023
2564
0.110
Why?
Biosensing Techniques
2
2013
118
0.110
Why?
Administration, Oral
5
2012
787
0.110
Why?
Bronchopulmonary Dysplasia
1
2019
379
0.110
Why?
Adrenal Gland Neoplasms
1
2015
83
0.110
Why?
Correction of Hearing Impairment
1
2014
15
0.110
Why?
Transcription Factors
3
2010
1647
0.110
Why?
Attitude to Computers
1
2014
28
0.110
Why?
Tomography, Spiral Computed
1
2013
27
0.110
Why?
Lymph Node Excision
1
2015
164
0.110
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2014
51
0.110
Why?
Persons With Hearing Impairments
1
2014
23
0.110
Why?
Genetic Testing
2
2011
430
0.110
Why?
PUVA Therapy
3
1990
6
0.110
Why?
Multiplex Polymerase Chain Reaction
1
2014
51
0.110
Why?
Interferon-gamma
3
1995
772
0.110
Why?
Activities of Daily Living
1
2016
382
0.110
Why?
Inhibitory Concentration 50
3
2013
86
0.100
Why?
Proto-Oncogene Proteins c-akt
5
2015
432
0.100
Why?
Deltaretrovirus Infections
3
1988
6
0.100
Why?
Physicians
2
2019
866
0.100
Why?
Sequence Analysis, DNA
2
2014
778
0.100
Why?
Wnt Proteins
2
2012
127
0.100
Why?
Retroviridae
9
1983
99
0.100
Why?
Hearing Aids
1
2014
73
0.100
Why?
Hypogonadism
1
2013
84
0.100
Why?
DNA
6
1983
1404
0.100
Why?
Hyperplasia
2
2011
175
0.100
Why?
Loss of Heterozygosity
2
2002
46
0.100
Why?
Software
1
2017
608
0.100
Why?
Radioimmunotherapy
1
1992
16
0.100
Why?
Neurosecretory Systems
2
2017
31
0.090
Why?
Risk Assessment
5
2010
3262
0.090
Why?
Polymerase Chain Reaction
3
2006
1035
0.090
Why?
Genetic Variation
1
2017
939
0.090
Why?
Risk Factors
9
2019
9786
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2014
949
0.090
Why?
Androgens
1
2013
177
0.090
Why?
Prostatic Neoplasms
5
2018
998
0.090
Why?
Meningeal Neoplasms
4
1986
93
0.090
Why?
Molecular Sequence Data
6
1999
2835
0.090
Why?
Benzamides
1
2012
203
0.090
Why?
Histones
1
2016
589
0.090
Why?
Clinical Trials, Phase I as Topic
2
2002
51
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
56
0.090
Why?
Deltaretrovirus
6
1986
12
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
3
2015
81
0.090
Why?
Antibiotics, Antitubercular
11
1961
37
0.090
Why?
Cervical Vertebrae
2
2002
132
0.090
Why?
MAP Kinase Kinase 1
3
2015
75
0.090
Why?
Antibody Formation
2
2022
291
0.090
Why?
Gold
1
2011
118
0.090
Why?
Cognition
2
2009
1129
0.090
Why?
Hearing Loss
1
2014
210
0.090
Why?
Zinc Finger E-box-Binding Homeobox 1
2
2010
23
0.090
Why?
Isoenzymes
2
2004
301
0.090
Why?
Molecular Structure
2
2005
481
0.080
Why?
Pulmonary Surgical Procedures
1
2010
8
0.080
Why?
Radionuclide Imaging
13
1991
122
0.080
Why?
Transcriptome
1
2016
876
0.080
Why?
Mucins
1
1990
70
0.080
Why?
Dermatologic Agents
11
1961
65
0.080
Why?
Radiography
9
2002
797
0.080
Why?
Stomach Neoplasms
3
1982
98
0.080
Why?
Tuberculosis
19
1970
273
0.080
Why?
Indium
5
1987
9
0.080
Why?
Placebos
3
2019
201
0.080
Why?
Testosterone
1
2013
372
0.080
Why?
Neoplasm Invasiveness
3
2015
481
0.080
Why?
Random Allocation
7
2017
347
0.080
Why?
Expressed Emotion
1
2009
18
0.080
Why?
Tumor Virus Infections
3
1984
46
0.080
Why?
Lymphoma, B-Cell
1
2010
105
0.080
Why?
Tocopherols
1
2009
25
0.080
Why?
Isotretinoin
1
2009
23
0.080
Why?
Antibodies, Neoplasm
4
2001
34
0.080
Why?
Vasodilator Agents
1
2011
326
0.080
Why?
Central Nervous System Diseases
2
1983
69
0.080
Why?
Staphylococcal Infections
7
1981
389
0.080
Why?
Catheter Ablation
1
2012
336
0.080
Why?
Blotting, Western
6
2014
1206
0.080
Why?
Pulmonary Disease, Chronic Obstructive
2
2007
984
0.080
Why?
Kanamycin
6
1970
8
0.080
Why?
Wounds, Nonpenetrating
2
2002
272
0.080
Why?
Spinal Cord Neoplasms
4
1986
36
0.080
Why?
Fluorenes
1
2009
40
0.080
Why?
Mitogen-Activated Protein Kinases
2
2002
312
0.080
Why?
MicroRNAs
2
2012
679
0.070
Why?
Receptors, Fibroblast Growth Factor
1
2008
65
0.070
Why?
Cell Survival
5
2013
1076
0.070
Why?
Aneuploidy
5
2010
92
0.070
Why?
Podophyllotoxin
3
2003
7
0.070
Why?
Reproducibility of Results
4
2023
3080
0.070
Why?
Vincristine
13
1989
108
0.070
Why?
Amides
1
2009
91
0.070
Why?
Rats, Nude
4
2003
27
0.070
Why?
Rats
6
2005
5483
0.070
Why?
Multigene Family
2
2006
199
0.070
Why?
Lymphatic Metastasis
6
2020
320
0.070
Why?
Social Perception
1
2009
104
0.070
Why?
Mice, Inbred BALB C
4
2004
1250
0.070
Why?
National Institutes of Health (U.S.)
4
1996
122
0.070
Why?
Antisocial Personality Disorder
1
2009
163
0.070
Why?
Sample Size
1
2008
116
0.070
Why?
Polymorphism, Genetic
1
2011
637
0.070
Why?
Kinetics
8
1991
1645
0.070
Why?
Multivariate Analysis
5
2016
1499
0.070
Why?
Patient Acceptance of Health Care
1
2014
761
0.070
Why?
Chromosome Aberrations
6
1993
147
0.070
Why?
Bombesin
3
1994
11
0.070
Why?
Models, Statistical
1
1991
625
0.070
Why?
Drug Evaluation, Preclinical
2
2002
171
0.070
Why?
Fibroblast Growth Factors
1
2008
169
0.070
Why?
Nanoparticles
1
2011
375
0.070
Why?
Inflammation
1
2018
2750
0.070
Why?
Immunoglobulins
2
1985
161
0.070
Why?
Epithelial Cells
4
2007
1075
0.070
Why?
Exons
2
2019
342
0.070
Why?
Incidence
3
2018
2641
0.070
Why?
Receptors, Growth Factor
2
1997
55
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2002
338
0.070
Why?
Epitopes
3
1986
472
0.070
Why?
Psychological Tests
1
2007
136
0.070
Why?
Congresses as Topic
3
2020
216
0.070
Why?
Radioisotopes
4
1987
31
0.070
Why?
Databases, Genetic
2
2018
230
0.060
Why?
Bevacizumab
1
2007
128
0.060
Why?
Mesoderm
1
2007
138
0.060
Why?
Cytokines
4
1997
2021
0.060
Why?
Radioimmunoassay
3
1986
175
0.060
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1987
67
0.060
Why?
Tegafur
1
2005
3
0.060
Why?
Immunologic Factors
3
1996
230
0.060
Why?
Platinum Compounds
1
2005
10
0.060
Why?
Uracil
1
2005
31
0.060
Why?
Aging
2
2014
1778
0.060
Why?
Teniposide
2
2003
3
0.060
Why?
Receptors, Cell Surface
2
2001
381
0.060
Why?
In Situ Nick-End Labeling
2
2003
123
0.060
Why?
Area Under Curve
2
2005
304
0.060
Why?
Vascular Endothelial Growth Factor A
1
2008
530
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2014
1280
0.060
Why?
beta 2-Microglobulin
1
1985
49
0.060
Why?
Resting Phase, Cell Cycle
1
2005
15
0.060
Why?
Adolescent
10
2020
20412
0.060
Why?
Anti-Infective Agents
4
2001
247
0.060
Why?
Matrix Metalloproteinase Inhibitors
2
2005
15
0.060
Why?
Affect
1
2007
288
0.060
Why?
Drug Resistance
5
2006
165
0.060
Why?
PTEN Phosphohydrolase
1
2006
161
0.060
Why?
G1 Phase
1
2005
70
0.060
Why?
Radiation, Ionizing
1
2005
76
0.060
Why?
Binding Sites, Antibody
1
1984
42
0.060
Why?
Injections, Subcutaneous
3
2002
147
0.060
Why?
Regression Analysis
3
2003
997
0.060
Why?
Selenium
2
2004
36
0.060
Why?
Drug Therapy
5
1983
80
0.060
Why?
Radiotherapy
6
1994
185
0.060
Why?
Data Collection
1
2007
650
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2018
487
0.060
Why?
Animal Welfare
1
2004
14
0.060
Why?
Biological Therapy
1
2004
28
0.060
Why?
Bortezomib
1
2004
45
0.060
Why?
Retroviridae Infections
4
1985
46
0.060
Why?
JNK Mitogen-Activated Protein Kinases
2
2002
161
0.060
Why?
Karyotyping
6
1996
107
0.050
Why?
Retinoids
1
2004
33
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
72
0.050
Why?
Planning Techniques
1
2003
16
0.050
Why?
Immunologic Tests
1
2023
16
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
3
1976
114
0.050
Why?
Decision Making, Organizational
1
2003
27
0.050
Why?
Nucleocapsid
1
2023
18
0.050
Why?
Surveys and Questionnaires
4
2014
5415
0.050
Why?
Biotechnology
1
2004
39
0.050
Why?
Vaccination
2
2022
1347
0.050
Why?
Lymphocytes
1
1985
378
0.050
Why?
Vitamin E
1
2004
120
0.050
Why?
Necrosis
1
2004
232
0.050
Why?
Transfection
1
2006
915
0.050
Why?
Nervous System Neoplasms
1
1983
2
0.050
Why?
Methotrexate
11
1986
249
0.050
Why?
Diagnostic Imaging
2
2009
325
0.050
Why?
Immunotoxins
2
1995
54
0.050
Why?
Cyclooxygenase 2
1
2004
176
0.050
Why?
Radiation Tolerance
1
2004
98
0.050
Why?
Methylmalonic Acid
1
2002
62
0.050
Why?
Meninges
4
1982
42
0.050
Why?
Pilot Projects
3
2012
1592
0.050
Why?
Pandemics
2
2022
1491
0.050
Why?
Killer Cells, Natural
2
1988
426
0.050
Why?
Fruit
1
2003
133
0.050
Why?
Enzyme Activation
2
2002
813
0.050
Why?
Proteomics
3
2007
1055
0.050
Why?
Farnesyltranstransferase
1
2002
35
0.050
Why?
Epithelial-Mesenchymal Transition
2
2017
201
0.050
Why?
Vegetables
1
2003
148
0.050
Why?
Skin
7
1987
727
0.050
Why?
Automation
1
2002
81
0.050
Why?
Streptozocin
3
1983
20
0.050
Why?
Autoradiography
3
1981
73
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2007
756
0.050
Why?
Metaplasia
2
2018
57
0.050
Why?
Injections, Intralesional
1
2002
33
0.050
Why?
Infusion Pumps
1
2002
31
0.050
Why?
Parents
2
2009
1316
0.050
Why?
Tetrazolium Salts
1
2002
17
0.050
Why?
Injections, Intraperitoneal
1
2002
112
0.050
Why?
Homocysteine
1
2002
152
0.050
Why?
SEER Program
1
2003
202
0.050
Why?
Hypercalcemia
4
1986
21
0.050
Why?
Peptides
3
2001
926
0.050
Why?
Proteome
1
2006
438
0.050
Why?
Antigen-Antibody Complex
4
1986
85
0.050
Why?
Mechlorethamine
3
1994
63
0.050
Why?
Metalloendopeptidases
2
2002
59
0.050
Why?
Testis
1
2002
145
0.050
Why?
Mediastinal Neoplasms
1
2002
38
0.050
Why?
Infusions, Intravenous
3
2004
399
0.050
Why?
Indoles
1
2024
383
0.050
Why?
Multicenter Studies as Topic
1
2003
286
0.050
Why?
Ciprofloxacin
1
2001
30
0.050
Why?
Thiazoles
1
2002
117
0.050
Why?
Dietary Supplements
2
2004
534
0.050
Why?
Confidence Intervals
2
2017
317
0.050
Why?
Pedigree
3
2000
487
0.050
Why?
Leukopenia
5
1995
28
0.050
Why?
Kinins
1
2001
3
0.050
Why?
Endpoint Determination
1
2001
76
0.040
Why?
Double-Blind Method
2
2019
1875
0.040
Why?
Pyrimidines
1
2024
459
0.040
Why?
Fluorescence
1
2001
155
0.040
Why?
HIV Infections
1
1996
2730
0.040
Why?
Receptors, Antigen, T-Cell
1
1985
708
0.040
Why?
Neoplastic Cells, Circulating
2
1984
70
0.040
Why?
Endothelium, Vascular
2
2004
903
0.040
Why?
Leukemia, Plasma Cell
1
1980
4
0.040
Why?
Hypergammaglobulinemia
1
1980
9
0.040
Why?
Central Nervous System
1
2023
255
0.040
Why?
Paraproteinemias
1
1980
5
0.040
Why?
Plasmacytoma
1
1980
16
0.040
Why?
Sensitivity and Specificity
3
2015
1843
0.040
Why?
Cell Count
3
1996
312
0.040
Why?
Lymphoproliferative Disorders
3
1988
54
0.040
Why?
Microscopy, Fluorescence
1
2002
399
0.040
Why?
Receptors, Interleukin-2
2
1995
64
0.040
Why?
Microtubules
1
2003
263
0.040
Why?
Antioxidants
1
2004
558
0.040
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2020
55
0.040
Why?
Telomerase
1
2002
234
0.040
Why?
Ploidies
4
2003
17
0.040
Why?
Receptors, Virus
1
2020
83
0.040
Why?
Histocompatibility Antigens Class II
2
2020
363
0.040
Why?
Genes, Tumor Suppressor
1
2000
87
0.040
Why?
Lipoxygenase Inhibitors
1
1999
38
0.040
Why?
Algorithms
3
2015
1616
0.040
Why?
Observer Variation
1
2020
314
0.040
Why?
ELAV Proteins
1
1999
14
0.040
Why?
Gene Transfer Techniques
2
1998
161
0.040
Why?
Costs and Cost Analysis
1
2000
201
0.040
Why?
Carcinoembryonic Antigen
1
1979
39
0.040
Why?
Sepsis
3
1981
575
0.040
Why?
Stomach Diseases
1
1979
20
0.040
Why?
Streptomycin
8
1954
16
0.040
Why?
Feasibility Studies
2
2000
869
0.040
Why?
Electrons
4
1989
77
0.040
Why?
Light
1
2001
359
0.040
Why?
Stomach
1
1979
109
0.040
Why?
Antibodies
3
1990
398
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Desmoglein 3
1
2018
15
0.040
Why?
Protein Kinase C
1
2000
262
0.040
Why?
Spinal Cord Injuries
1
2002
194
0.040
Why?
Administration, Topical
2
1994
147
0.040
Why?
History, 20th Century
2
1996
294
0.040
Why?
Smokers
1
2019
138
0.040
Why?
Case-Control Studies
3
2012
3378
0.040
Why?
HIV Wasting Syndrome
1
1998
4
0.040
Why?
Bronchial Diseases
1
2018
37
0.040
Why?
Postoperative Care
1
2000
241
0.040
Why?
Carcinoma
4
2001
214
0.040
Why?
Hematologic Diseases
3
1995
62
0.040
Why?
Colorectal Neoplasms
2
2013
749
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Teaching
1
2020
217
0.040
Why?
Models, Molecular
2
2018
1491
0.040
Why?
Tissue Distribution
5
1990
315
0.040
Why?
RNA, Small Interfering
2
2012
591
0.040
Why?
Skin Diseases
2
1979
143
0.040
Why?
Pneumonia
6
1968
617
0.040
Why?
Retinoblastoma Binding Proteins
1
2017
5
0.040
Why?
Genes, p53
1
1998
70
0.040
Why?
Organoids
1
2019
104
0.040
Why?
DNA Topoisomerases, Type I
1
2017
14
0.040
Why?
Type C Phospholipases
1
1998
72
0.040
Why?
Communicable Diseases
4
1964
152
0.040
Why?
Preoperative Care
1
2000
338
0.040
Why?
North America
1
1998
292
0.030
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
181
0.030
Why?
Web Browser
1
2017
12
0.030
Why?
Drug Resistance, Multiple
1
1997
25
0.030
Why?
Demecolcine
1
1976
1
0.030
Why?
Receptors, Notch
1
2017
84
0.030
Why?
Endocarditis, Subacute Bacterial
3
1964
3
0.030
Why?
Mice, SCID
1
2017
350
0.030
Why?
Risk
5
2001
855
0.030
Why?
Bronchial Neoplasms
1
1996
14
0.030
Why?
B-Lymphocytes
5
1986
816
0.030
Why?
Platinum
1
2016
44
0.030
Why?
T-Lymphocytes, Helper-Inducer
2
1996
135
0.030
Why?
Maximum Tolerated Dose
2
2007
193
0.030
Why?
Tuberculosis, Ocular
5
1954
7
0.030
Why?
Registries
1
2024
1899
0.030
Why?
Ubiquitin-Protein Ligases
1
2017
156
0.030
Why?
Longitudinal Studies
1
2003
2720
0.030
Why?
Mitogens
4
1998
60
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
181
0.030
Why?
Endocarditis
3
1964
38
0.030
Why?
Carcinogenesis
1
2017
213
0.030
Why?
Receptors, Cytokine
1
1996
35
0.030
Why?
Drug Stability
1
1996
159
0.030
Why?
RNA-Binding Proteins
1
1999
387
0.030
Why?
Analgesics, Non-Narcotic
1
1997
120
0.030
Why?
Mice, Inbred NOD
1
2017
587
0.030
Why?
Diet
1
2003
1213
0.030
Why?
Comorbidity
2
2016
1547
0.030
Why?
Premedication
1
1995
42
0.030
Why?
Growth Inhibitors
2
2002
44
0.030
Why?
Colonic Neoplasms
1
2018
242
0.030
Why?
Meningitis
4
1974
79
0.030
Why?
Rabbits
10
2005
779
0.030
Why?
Hematopoiesis
1
1976
184
0.030
Why?
Cross-Linking Reagents
1
1996
205
0.030
Why?
Pathology, Molecular
1
2015
25
0.030
Why?
Severity of Illness Index
1
2003
2739
0.030
Why?
GTP-Binding Proteins
1
1996
158
0.030
Why?
Interferon-beta
1
1995
89
0.030
Why?
Military Medicine
1
1996
63
0.030
Why?
HLA-A Antigens
2
1985
53
0.030
Why?
Ovarian Neoplasms
1
2000
484
0.030
Why?
Drug Tolerance
1
1995
90
0.030
Why?
Biological Specimen Banks
1
1996
97
0.030
Why?
HLA-C Antigens
2
1985
35
0.030
Why?
Guinea Pigs
3
2005
157
0.030
Why?
Diphtheria Toxin
1
1995
65
0.030
Why?
Colorado
2
2014
4404
0.030
Why?
HLA-B Antigens
2
1985
62
0.030
Why?
Photopheresis
1
1994
9
0.030
Why?
Whole-Body Irradiation
3
1991
76
0.030
Why?
Bone Marrow Transplantation
2
1986
277
0.030
Why?
Antigens, Viral
4
1984
179
0.030
Why?
Wnt Signaling Pathway
1
2016
170
0.030
Why?
Proteins
1
2000
944
0.030
Why?
Mitomycin
2
1992
32
0.030
Why?
Glioblastoma
1
2018
322
0.030
Why?
Cholecystokinin
1
1994
13
0.030
Why?
Molecular Diagnostic Techniques
1
2015
98
0.030
Why?
Cell Cycle Proteins
1
2018
584
0.030
Why?
Methoxsalen
1
1994
4
0.030
Why?
Substance P
1
1994
43
0.030
Why?
Ultraviolet Therapy
1
1994
16
0.030
Why?
gamma-Globulins
2
1965
18
0.030
Why?
Research
2
1994
419
0.030
Why?
Contraindications
1
1994
90
0.030
Why?
Histiocytoma, Benign Fibrous
1
1994
8
0.030
Why?
Glioma
1
2018
348
0.030
Why?
Odds Ratio
1
2016
1019
0.030
Why?
Texas
1
2014
237
0.030
Why?
Pyridazines
1
2014
54
0.030
Why?
Serum Albumin
2
2013
149
0.030
Why?
Micrococcus
3
1958
4
0.030
Why?
Tumor Stem Cell Assay
3
1992
32
0.030
Why?
Fibroblasts
1
1998
953
0.030
Why?
Staphylococcus
3
1970
74
0.030
Why?
Safety
1
1995
335
0.030
Why?
DNA-Binding Proteins
1
2000
1445
0.030
Why?
DNA Fingerprinting
1
2013
26
0.030
Why?
Muscle Denervation
1
1973
10
0.030
Why?
Consensus
1
2016
618
0.030
Why?
Sex Hormone-Binding Globulin
1
2013
53
0.030
Why?
Endoscopy
1
2015
288
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
329
0.030
Why?
Ileum
2
2005
116
0.030
Why?
Maintenance Chemotherapy
1
2013
22
0.030
Why?
Urinary Tract Infections
3
1970
151
0.030
Why?
In Vitro Techniques
5
2002
1087
0.030
Why?
Imidazoles
1
2014
234
0.030
Why?
Solid Phase Microextraction
1
2012
8
0.030
Why?
Treatment Failure
1
1994
339
0.030
Why?
Radiation Dosage
2
1992
154
0.030
Why?
Magnetic Resonance Imaging
2
2023
3394
0.030
Why?
Auditory Perception
1
2014
113
0.030
Why?
DNA Primers
2
2009
511
0.030
Why?
NAD(P)H Dehydrogenase (Quinone)
1
1992
32
0.020
Why?
Neuromuscular Junction
1
1973
58
0.020
Why?
Chromosome Banding
4
1996
21
0.020
Why?
Luteinizing Hormone
1
2013
178
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
130
0.020
Why?
Hearing
1
2014
135
0.020
Why?
Breath Tests
1
2012
87
0.020
Why?
Pyrimidinones
1
2013
102
0.020
Why?
Mitomycins
2
1984
4
0.020
Why?
Recombinant Fusion Proteins
1
1995
651
0.020
Why?
International Cooperation
2
2003
175
0.020
Why?
Adrenocorticotropic Hormone
4
1954
133
0.020
Why?
Cooperative Behavior
1
2015
433
0.020
Why?
Bone Marrow Examination
1
1992
6
0.020
Why?
Species Specificity
2
2005
574
0.020
Why?
Ionomycin
1
1992
25
0.020
Why?
Probability
3
2009
306
0.020
Why?
Ricin
1
1991
8
0.020
Why?
Equipment Design
1
2014
514
0.020
Why?
Nanostructures
1
2013
100
0.020
Why?
Immunization, Passive
2
2001
86
0.020
Why?
Benzimidazoles
1
2013
162
0.020
Why?
Chromosome Deletion
2
1982
104
0.020
Why?
Properdin
2
1962
9
0.020
Why?
Radiometry
1
1992
47
0.020
Why?
Gene Frequency
1
2013
502
0.020
Why?
Follicle Stimulating Hormone
1
2013
237
0.020
Why?
Liver
5
1987
1842
0.020
Why?
Drug Hypersensitivity
2
1970
81
0.020
Why?
Ambulatory Care
1
1995
506
0.020
Why?
Fatigue
2
2005
318
0.020
Why?
Logistic Models
1
2016
1986
0.020
Why?
Immunosorbent Techniques
1
1991
19
0.020
Why?
Pyridones
1
2013
158
0.020
Why?
Tuberculosis, Pulmonary
4
1959
135
0.020
Why?
Laboratories
2
1963
108
0.020
Why?
Acquired Immunodeficiency Syndrome
2
1990
228
0.020
Why?
Waldenstrom Macroglobulinemia
2
1982
11
0.020
Why?
Lomustine
7
1986
14
0.020
Why?
Iceland
1
2011
10
0.020
Why?
Japan
2
2009
98
0.020
Why?
Evidence-Based Medicine
1
2015
712
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Vimentin
1
2011
50
0.020
Why?
Spain
1
2011
34
0.020
Why?
Perception
1
2014
344
0.020
Why?
Antibodies, Anti-Idiotypic
1
1991
58
0.020
Why?
Adsorption
1
1991
139
0.020
Why?
Mutation, Missense
1
2013
318
0.020
Why?
Netherlands
1
2011
77
0.020
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
834
0.020
Why?
Zinc Finger E-box Binding Homeobox 2
1
2010
5
0.020
Why?
Residence Characteristics
1
2014
331
0.020
Why?
Cross-Sectional Studies
2
2015
5075
0.020
Why?
Motor Neurons
1
1973
234
0.020
Why?
Databases, Factual
1
1996
1269
0.020
Why?
Photochemotherapy
2
1980
32
0.020
Why?
Megakaryocytes
3
1980
32
0.020
Why?
Tissue Array Analysis
1
2010
55
0.020
Why?
Diagnosis, Differential
2
2002
1432
0.020
Why?
Sequence Homology, Nucleic Acid
1
1990
151
0.020
Why?
Base Sequence
2
2009
2147
0.020
Why?
Radiotherapy, High-Energy
2
1980
13
0.020
Why?
Thyroid Neoplasms
1
1994
312
0.020
Why?
Serine Endopeptidases
1
2010
120
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
2
1988
20
0.020
Why?
Nervous System Diseases
3
1985
251
0.020
Why?
Clone Cells
3
1985
262
0.020
Why?
Carrier Proteins
1
1994
745
0.020
Why?
Nicotinic Acids
3
1954
6
0.020
Why?
Hemagglutination Tests
2
1964
7
0.020
Why?
Niacin
3
1954
19
0.020
Why?
Down-Regulation
1
1992
636
0.020
Why?
Mitosis
3
1981
180
0.020
Why?
Calcitriol
2
1986
54
0.020
Why?
Bacterial Infections
2
2001
235
0.020
Why?
Deafness
1
1970
80
0.020
Why?
Diethylstilbestrol
2
1986
9
0.020
Why?
Isoniazid
3
1954
63
0.020
Why?
Personality Inventory
1
2009
139
0.020
Why?
Immunoprecipitation
1
2009
157
0.020
Why?
Infusions, Parenteral
2
1986
38
0.020
Why?
Insulin-Like Growth Factor I
1
1991
306
0.020
Why?
Referral and Consultation
1
2014
730
0.020
Why?
Ovary
1
1990
209
0.020
Why?
Thoracic Surgery
1
2010
123
0.020
Why?
Histocytochemistry
3
1983
81
0.020
Why?
Tuberculosis, Meningeal
4
1964
6
0.020
Why?
Tomography, X-Ray Computed
3
2002
2512
0.020
Why?
Herpes Simplex
2
1987
92
0.020
Why?
Statistics, Nonparametric
1
2009
419
0.020
Why?
Fluorescent Antibody Technique
2
1987
376
0.020
Why?
Tetracycline
2
1958
12
0.020
Why?
In Situ Hybridization
1
2008
297
0.020
Why?
Pulmonary Fibrosis
2
1986
385
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2011
441
0.020
Why?
Bone Marrow Cells
3
1980
302
0.020
Why?
New South Wales
1
2007
14
0.020
Why?
Rosette Formation
2
1987
16
0.020
Why?
Queensland
1
2007
40
0.020
Why?
Immunophenotyping
2
2001
311
0.020
Why?
Ampicillin
2
1965
14
0.020
Why?
Eye
3
1954
105
0.020
Why?
Protein Synthesis Inhibitors
2
1958
44
0.020
Why?
Actuarial Analysis
1
1987
26
0.020
Why?
Body Fluids
2
1964
63
0.020
Why?
Fluorouracil
2
1998
197
0.020
Why?
Remission, Spontaneous
4
1980
38
0.020
Why?
Repressor Proteins
1
2010
406
0.020
Why?
Receptors, Progesterone
1
1989
341
0.020
Why?
Pneumonia, Pneumococcal
2
1960
42
0.020
Why?
Procarbazine
5
1986
8
0.020
Why?
Dyspnea
2
1986
239
0.020
Why?
Principal Component Analysis
1
2007
190
0.020
Why?
Genome, Human
1
2009
394
0.020
Why?
Hydrocortisone
2
1981
306
0.020
Why?
Calcitonin
1
1986
27
0.020
Why?
Genome
1
2009
278
0.020
Why?
Nucleotidases
2
1985
7
0.020
Why?
California
1
2008
400
0.020
Why?
Colony-Forming Units Assay
1
1986
90
0.020
Why?
Reference Values
1
2008
794
0.020
Why?
Bacillus
2
1957
15
0.020
Why?
Phosphates
2
1958
179
0.020
Why?
DNA Repair
1
2008
210
0.020
Why?
Sulfadiazine
1
1966
4
0.020
Why?
Gram-Positive Bacteria
2
1957
44
0.020
Why?
Nocardia Infections
1
1966
9
0.020
Why?
Insecta
2
1957
64
0.020
Why?
Antigen-Antibody Reactions
1
1966
52
0.020
Why?
Radioisotope Dilution Technique
1
1986
13
0.020
Why?
Farmer's Lung
1
1965
3
0.020
Why?
Immunoglobulin Idiotypes
1
1986
27
0.020
Why?
Dose-Response Relationship, Immunologic
1
1986
82
0.020
Why?
Vomiting
3
2001
129
0.020
Why?
Erythromycin
2
1958
24
0.020
Why?
Mice, Inbred A
1
2005
48
0.020
Why?
Child
4
2009
20884
0.020
Why?
Deoxyribonucleosides
1
1985
2
0.020
Why?
Urea
1
1966
76
0.020
Why?
Databases, Nucleic Acid
1
2005
33
0.020
Why?
Dose-Response Relationship, Radiation
1
1986
132
0.020
Why?
Indicators and Reagents
1
1986
109
0.020
Why?
Child, Preschool
3
2007
10490
0.020
Why?
Freezing
1
1986
87
0.020
Why?
Peritonitis
1
1966
81
0.020
Why?
DNA Damage
1
2008
384
0.020
Why?
Mathematics
1
1986
102
0.020
Why?
Cell Movement
2
1981
948
0.020
Why?
HLA-B35 Antigen
1
1985
3
0.020
Why?
Blood
1
1985
105
0.020
Why?
Analysis of Variance
1
2008
1293
0.010
Why?
HLA-B8 Antigen
1
1985
14
0.010
Why?
Enzymes
1
2005
65
0.010
Why?
Bleomycin
2
1978
243
0.010
Why?
Mycoses
1
1966
72
0.010
Why?
Carcinogens
1
2005
110
0.010
Why?
Phenylalanine
1
2005
65
0.010
Why?
Nucleic Acid Hybridization
1
1985
189
0.010
Why?
Antigens, Differentiation, T-Lymphocyte
1
1985
88
0.010
Why?
Genes, MHC Class II
1
1985
73
0.010
Why?
Myeloma Proteins
1
1984
14
0.010
Why?
Lymphokines
1
1985
127
0.010
Why?
Haemophilus
1
1965
6
0.010
Why?
Exanthema
1
2005
74
0.010
Why?
Melphalan
1
1984
29
0.010
Why?
Endocytosis
1
1986
162
0.010
Why?
Histocompatibility Testing
1
1985
120
0.010
Why?
Viral Proteins
3
1981
327
0.010
Why?
Carmustine
1
1984
50
0.010
Why?
Monocytes
2
1985
553
0.010
Why?
Tyrosine
1
2005
223
0.010
Why?
Syndrome
3
1984
340
0.010
Why?
Endocarditis, Bacterial
1
1965
42
0.010
Why?
Cross Reactions
1
1984
133
0.010
Why?
Psychology, Child
1
2004
38
0.010
Why?
Nausea
2
2001
111
0.010
Why?
Hemagglutination
1
1964
8
0.010
Why?
Genome-Wide Association Study
1
2011
1326
0.010
Why?
Bronchopneumonia
1
1964
6
0.010
Why?
Acetaminophen
1
1987
247
0.010
Why?
DNA, Recombinant
1
1984
46
0.010
Why?
Acute Disease
2
1984
979
0.010
Why?
DNA Replication
1
2005
227
0.010
Why?
Nephritis, Interstitial
1
1984
13
0.010
Why?
Expectorants
1
1964
24
0.010
Why?
Nephrosis, Lipoid
1
1984
10
0.010
Why?
Hypersensitivity, Delayed
1
1983
28
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2005
285
0.010
Why?
Densitometry
2
1980
34
0.010
Why?
Chromosomes, Human, Pair 7
1
2003
15
0.010
Why?
Prednisone
1
1984
234
0.010
Why?
Cell Transformation, Viral
2
1984
27
0.010
Why?
Chromosomes
2
1982
101
0.010
Why?
Paraneoplastic Syndromes
1
1983
11
0.010
Why?
Muscles
3
1982
320
0.010
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2003
17
0.010
Why?
Toxicology
1
1964
41
0.010
Why?
Virus Diseases
1
1966
210
0.010
Why?
Growth Hormone
2
1954
96
0.010
Why?
Allergy and Immunology
1
1964
42
0.010
Why?
Biopsy, Needle
2
1982
188
0.010
Why?
Vital Capacity
1
2004
289
0.010
Why?
Cloxacillin
1
1963
1
0.010
Why?
Transfer Factor
1
1983
1
0.010
Why?
Tuberculosis, Miliary
3
1964
5
0.010
Why?
Furunculosis
1
1962
1
0.010
Why?
Sex Ratio
1
1983
13
0.010
Why?
Vitamins
1
2004
173
0.010
Why?
Razoxane
1
1982
1
0.010
Why?
Receptors, Bradykinin
1
2002
5
0.010
Why?
Leukapheresis
1
1983
21
0.010
Why?
Thymosin
2
1980
5
0.010
Why?
Cell Membrane
2
2002
734
0.010
Why?
Antilymphocyte Serum
1
1983
63
0.010
Why?
Mycobacterium tuberculosis
2
1957
309
0.010
Why?
Poly(ADP-ribose) Polymerases
1
2003
94
0.010
Why?
Drainage
1
1964
164
0.010
Why?
Pneumococcal Infections
2
1956
112
0.010
Why?
Pentosyltransferases
1
1982
3
0.010
Why?
T-Lymphocytes, Cytotoxic
1
1983
170
0.010
Why?
Lymphocyte Activation
3
1983
1109
0.010
Why?
Nucleoside Deaminases
1
1982
2
0.010
Why?
Purine-Nucleoside Phosphorylase
1
1982
5
0.010
Why?
Bacteriophages
2
1961
86
0.010
Why?
Autopsy
1
1983
90
0.010
Why?
Cells, Cultured
7
1985
4084
0.010
Why?
Streptococcal Infections
1
1965
148
0.010
Why?
Forced Expiratory Volume
1
2004
506
0.010
Why?
Adenosine Deaminase
1
1982
29
0.010
Why?
Keratins
1
2003
175
0.010
Why?
Immunity, Cellular
2
1984
265
0.010
Why?
Cysteine
1
1964
195
0.010
Why?
Umbilical Cord
1
2002
83
0.010
Why?
Agglutinins
1
1962
2
0.010
Why?
Clinical Enzyme Tests
1
1982
10
0.010
Why?
Phosphopyruvate Hydratase
1
1982
26
0.010
Why?
Gastrointestinal Tract
1
2004
186
0.010
Why?
Aggression
1
2004
201
0.010
Why?
Leukemia, Erythroblastic, Acute
1
1982
7
0.010
Why?
Abdominal Neoplasms
1
1982
34
0.010
Why?
Receptors, Fc
1
1982
52
0.010
Why?
Manipulation, Spinal
1
2002
7
0.010
Why?
Caspases
1
2003
245
0.010
Why?
Rectal Diseases
1
1981
19
0.010
Why?
Complement System Proteins
2
1962
318
0.010
Why?
Bone Resorption
1
1982
80
0.010
Why?
False Positive Reactions
1
2002
115
0.010
Why?
Sulfonamides
2
1955
497
0.010
Why?
Receptors, Immunologic
1
1983
217
0.010
Why?
Herpesvirus 4, Human
2
1980
156
0.010
Why?
Immune System
1
1983
175
0.010
Why?
Promoter Regions, Genetic
1
2006
1207
0.010
Why?
Oculomotor Muscles
2
1951
38
0.010
Why?
CD52 Antigen
1
2001
4
0.010
Why?
Spinal Fractures
1
2002
83
0.010
Why?
Alemtuzumab
1
2001
15
0.010
Why?
Zymosan
1
1961
65
0.010
Why?
Carcinoma, Hepatocellular
1
1983
272
0.010
Why?
Glasgow Coma Scale
1
2002
165
0.010
Why?
Phenotype
4
1984
3075
0.010
Why?
APUD Cells
1
1980
1
0.010
Why?
Single-Blind Method
1
2001
271
0.010
Why?
Furocoumarins
1
1980
8
0.010
Why?
Neoplasms, Hormone-Dependent
1
2000
38
0.010
Why?
Polysaccharides
1
1961
86
0.010
Why?
Hypersensitivity
1
1964
249
0.010
Why?
Cell Line, Transformed
1
2000
141
0.010
Why?
Hospitals, Chronic Disease
2
1958
2
0.010
Why?
Amyloidosis
1
1980
42
0.010
Why?
Immunoglobulin Heavy Chains
1
1980
80
0.010
Why?
Chromosomes, Human
1
1980
41
0.010
Why?
Intestinal Neoplasms
1
1980
28
0.010
Why?
Biological Assay
1
2001
118
0.010
Why?
Leukocytes
2
1984
306
0.010
Why?
Cytological Techniques
1
1980
27
0.010
Why?
Health Resources
1
2001
113
0.010
Why?
Neoplasm, Residual
1
2001
121
0.010
Why?
Piperazines
1
1982
340
0.010
Why?
Quality Assurance, Health Care
1
2002
317
0.010
Why?
Anemia
1
2001
161
0.010
Why?
Antiviral Agents
1
1966
715
0.010
Why?
Soft Tissue Neoplasms
1
1981
111
0.010
Why?
Disease Management
1
1964
588
0.010
Why?
Bacteremia
1
1962
194
0.010
Why?
Range of Motion, Articular
1
2002
367
0.010
Why?
Influenza, Human
1
1985
601
0.010
Why?
Joint Instability
1
2002
167
0.010
Why?
Thymus Hormones
1
1979
1
0.010
Why?
Brain
3
1985
2673
0.010
Why?
Carcinogens, Environmental
1
1979
7
0.010
Why?
Spinal Cord
1
1982
353
0.010
Why?
Osteoporosis
1
1982
230
0.010
Why?
Stomach Ulcer
1
1979
11
0.010
Why?
Gastroscopy
1
1979
18
0.010
Why?
Duodenal Ulcer
1
1979
11
0.010
Why?
History, 19th Century
1
1979
59
0.010
Why?
Cost-Benefit Analysis
1
2002
569
0.010
Why?
Glycoproteins
1
2001
338
0.010
Why?
Semustine
1
1978
1
0.010
Why?
Neuroblastoma
1
1980
151
0.010
Why?
Hybridomas
2
1994
235
0.010
Why?
Demeclocycline
1
1978
3
0.010
Why?
Spinal Cord Compression
1
1978
18
0.010
Why?
Blood Platelets
2
1984
382
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1998
28
0.010
Why?
Antigens, CD
1
2001
487
0.010
Why?
Protein Biosynthesis
1
2000
410
0.010
Why?
Phospholipase C beta
1
1998
30
0.010
Why?
Chloramphenicol
1
1958
9
0.010
Why?
Levamisole
1
1998
19
0.010
Why?
Vasopressins
1
1978
64
0.010
Why?
Gastritis
1
1979
96
0.010
Why?
Radiation Injuries
1
1979
135
0.010
Why?
Practice Patterns, Physicians'
1
2006
1271
0.010
Why?
Antibody Specificity
3
1983
184
0.010
Why?
Estradiol
1
1981
494
0.010
Why?
Cell Separation
3
1986
317
0.010
Why?
Hormones, Ectopic
1
1977
2
0.010
Why?
T-Lymphocytes, Regulatory
1
1980
373
0.010
Why?
Occupational Diseases
1
1979
138
0.010
Why?
Amantadine
2
1968
6
0.010
Why?
Thoracotomy
1
1997
74
0.010
Why?
GPI-Linked Proteins
1
1997
68
0.010
Why?
Vinca Alkaloids
1
1976
5
0.010
Why?
Genetic Markers
1
1998
336
0.010
Why?
Staining and Labeling
1
1977
142
0.010
Why?
Capsules
1
1957
40
0.010
Why?
Penicillin V
1
1956
3
0.010
Why?
Cephalosporins
2
1968
40
0.010
Why?
Immunoglobulin G
2
1994
851
0.010
Why?
Cycloserine
1
1956
5
0.010
Why?
Gentamicins
2
1968
54
0.010
Why?
Colchicine
1
1976
24
0.010
Why?
Pregnancy
1
1989
6417
0.010
Why?
Novobiocin
1
1956
5
0.010
Why?
Gallium Radioisotopes
1
1975
14
0.010
Why?
Arthritis
1
1957
90
0.010
Why?
Maryland
1
1996
46
0.010
Why?
Herpes Zoster
1
1980
317
0.010
Why?
Computer Communication Networks
1
1996
32
0.010
Why?
Sulfisoxazole
1
1955
1
0.010
Why?
Glycopeptides
1
1996
43
0.010
Why?
Laparoscopy
1
1980
450
0.010
Why?
Cerebrospinal Fluid
1
1976
91
0.010
Why?
Cyclic AMP
1
1996
238
0.010
Why?
Bronchoalveolar Lavage Fluid
1
1997
646
0.010
Why?
Folate Receptors, GPI-Anchored
1
1994
5
0.010
Why?
Portal System
1
1953
13
0.010
Why?
Streptococcus pneumoniae
1
1956
161
0.010
Why?
Phlebitis
1
1953
11
0.010
Why?
Leucomycins
1
1953
1
0.010
Why?
Dogs
2
1987
383
0.010
Why?
Respiratory Function Tests
2
1986
581
0.010
Why?
Veins
1
1953
60
0.010
Why?
Heart Neoplasms
1
1994
50
0.010
Why?
Thyroid Gland
1
1994
95
0.010
Why?
Isomerism
1
1953
53
0.010
Why?
Gallamine Triethiodide
1
1973
1
0.010
Why?
Edrophonium
1
1973
2
0.010
Why?
Organ Specificity
1
1994
296
0.010
Why?
Pulmonary Alveoli
1
1996
403
0.010
Why?
Disease
1
1953
95
0.010
Why?
Sciatic Nerve
1
1973
56
0.010
Why?
Human Growth Hormone
1
1953
45
0.010
Why?
Cats
1
1973
204
0.010
Why?
Chromosomes, Human, 1-3
2
1982
2
0.010
Why?
RNA, Neoplasm
1
1992
86
0.010
Why?
Meningitis, Pneumococcal
1
1952
7
0.010
Why?
Killer Cells, Lymphokine-Activated
1
1992
12
0.010
Why?
Appendicitis
1
1953
125
0.010
Why?
Cytotoxicity, Immunologic
2
1983
220
0.010
Why?
Electric Stimulation
1
1973
267
0.010
Why?
Recurrence
3
1980
1011
0.010
Why?
Models, Biological
1
1979
1724
0.010
Why?
Hormones
1
1952
141
0.010
Why?
Evaluation Studies as Topic
2
1982
175
0.010
Why?
Erythrocytes
1
1976
673
0.010
Why?
Perfusion
1
1992
197
0.010
Why?
Vestibulocochlear Nerve
1
1970
7
0.010
Why?
Klebsiella
1
1970
3
0.010
Why?
Blood Cell Count
2
1981
53
0.010
Why?
Organ of Corti
1
1970
14
0.010
Why?
Synaptic Transmission
1
1973
272
0.010
Why?
Insulin
1
1981
2326
0.010
Why?
Chlortetracycline
1
1950
4
0.010
Why?
Drug Resistance, Microbial
1
1970
69
0.010
Why?
Injections
1
1991
174
0.010
Why?
Culture Media
2
1981
162
0.010
Why?
Enterobacteriaceae Infections
1
1970
41
0.010
Why?
Microscopy, Electron
2
1982
426
0.010
Why?
Kidney
2
1984
1386
0.010
Why?
Paralysis
1
1970
69
0.010
Why?
Muscle Contraction
1
1973
423
0.010
Why?
Promegestone
1
1989
33
0.010
Why?
Chickenpox
1
1950
80
0.000
Why?
Action Potentials
1
1973
485
0.000
Why?
Formaldehyde
1
1989
60
0.000
Why?
Neuromuscular Diseases
1
1970
105
0.000
Why?
DNA Nucleotidyltransferases
1
1968
11
0.000
Why?
Thrombocythemia, Essential
1
1988
7
0.000
Why?
Polymyxins
1
1968
9
0.000
Why?
Immunoglobulin Isotypes
1
1987
34
0.000
Why?
Hepatic Insufficiency
1
1947
4
0.000
Why?
Whole-Body Counting
1
1987
6
0.000
Why?
Lysosomes
1
1968
137
0.000
Why?
Propidium
1
1986
8
0.000
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1988
118
0.000
Why?
Medroxyprogesterone
1
1986
10
0.000
Why?
Infant
1
1980
8995
0.000
Why?
Medroxyprogesterone Acetate
1
1986
35
0.000
Why?
Kidney Diseases
1
1970
383
0.000
Why?
Coloring Agents
1
1986
77
0.000
Why?
Orchiectomy
1
1986
67
0.000
Why?
Cephaloridine
1
1966
1
0.000
Why?
Immunodiffusion
1
1965
15
0.000
Why?
Immunoglobulin M
1
1987
276
0.000
Why?
Sulfanilamides
2
1955
2
0.000
Why?
Polymers
1
1989
477
0.000
Why?
Spleen
1
1987
509
0.000
Why?
Immunization
1
1987
411
0.000
Why?
Tuberculosis, Renal
1
1964
1
0.000
Why?
Canada
1
1965
350
0.000
Why?
Death, Sudden
1
1964
24
0.000
Why?
Polyethylene Glycols
1
1989
589
0.000
Why?
Purines
1
1985
172
0.000
Why?
Pathology
1
1964
22
0.000
Why?
Memory Disorders
1
1985
168
0.000
Why?
Molecular Weight
1
1984
329
0.000
Why?
Blood Cells
1
1984
39
0.000
Why?
Urticaria
1
1984
37
0.000
Why?
Cell Differentiation
2
1985
1891
0.000
Why?
West Indies
1
1983
4
0.000
Why?
Alabama
1
1983
33
0.000
Why?
Leukemia, Hairy Cell
1
1983
6
0.000
Why?
Leucovorin
1
1983
70
0.000
Why?
Aspartate Aminotransferases
1
1983
88
0.000
Why?
Georgia
1
1983
80
0.000
Why?
Respiratory Tract Infections
1
1968
376
0.000
Why?
Florida
1
1983
93
0.000
Why?
Skin Tests
1
1983
100
0.000
Why?
Warfarin
1
1984
147
0.000
Why?
Osteosclerosis
1
1982
2
0.000
Why?
Anemia, Sideroblastic
1
1982
3
0.000
Why?
Pulmonary Embolism
1
1964
212
0.000
Why?
Adrenal Glands
1
1982
70
0.000
Why?
Agranulocytosis
1
1981
30
0.000
Why?
Leukocyte Count
1
1982
326
0.000
Why?
Technetium Tc 99m Pyrophosphate
1
1981
1
0.000
Why?
Technetium
1
1981
12
0.000
Why?
Viral Core Proteins
1
1981
21
0.000
Why?
Creatinine
1
1983
490
0.000
Why?
Electrophysiology
1
1982
210
0.000
Why?
Diphosphates
1
1981
17
0.000
Why?
Peripheral Nerves
1
1982
69
0.000
Why?
Transferrin
1
1981
42
0.000
Why?
Abscess
1
1981
73
0.000
Why?
Immune Sera
1
1981
87
0.000
Why?
Fluorometry
1
1980
17
0.000
Why?
Photomicrography
1
1980
7
0.000
Why?
Mental Disorders
1
1949
1034
0.000
Why?
Microscopy, Phase-Contrast
1
1980
17
0.000
Why?
Substance-Related Disorders
1
1949
1020
0.000
Why?
DNA-Directed DNA Polymerase
1
1980
44
0.000
Why?
Haplorhini
1
1980
49
0.000
Why?
Dermatitis, Exfoliative
1
1980
4
0.000
Why?
Purpura
1
1980
14
0.000
Why?
Castration
1
1980
14
0.000
Why?
Macrophage Migration-Inhibitory Factors
1
1980
10
0.000
Why?
Alopecia
1
1979
30
0.000
Why?
Receptors, Complement
1
1980
122
0.000
Why?
Cocarcinogenesis
1
1979
14
0.000
Why?
Chemical Industry
1
1979
11
0.000
Why?
Receptors, Antigen, B-Cell
1
1980
126
0.000
Why?
Methods
1
1978
64
0.000
Why?
Fiber Optic Technology
1
1978
18
0.000
Why?
Hemoglobins
1
1981
339
0.000
Why?
Solvents
1
1979
108
0.000
Why?
Pesticides
1
1979
58
0.000
Why?
Mucous Membrane
1
1978
125
0.000
Why?
Granulocytes
1
1976
77
0.000
Why?
Herpesvirus 3, Human
1
1980
331
0.000
Why?
Air Pollutants
1
1979
314
0.000
Why?
Postoperative Complications
1
1983
2477
0.000
Why?
Hospitals, University
1
1946
178
0.000
Why?
Biological Transport
1
1946
404
0.000
Why?
Minnesota
1
1964
149
0.000
Why?
Students
1
1946
582
0.000
Why?
Bunn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)